http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-101457621-B1
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/B01D15-265 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07H1-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K36-258 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-704 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-704 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K36-258 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P3-10 |
| filingDate | 2012-01-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2014-11-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2014-11-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | KR-101457621-B1 |
| titleOfInvention | Methods for Preparing Rg3 or Rg2 Group Ginsenosides and Compositions for Preventing or Treating Metabolic Diseases |
| abstract | The present invention relates to a method for producing Rg3 group or Rg2 group ginsenoside and a composition for preventing or treating metabolic diseases. The present invention provides a method for preparing Rg3 group and Rg2 group ginsenoside, which is most optimized in terms of simplicity and efficiency. According to the present invention, at least 80% by weight of Rg3 group jinnenoside and Rg2 group jinnenoside can be obtained. The Rg3 group ginsenoside produced by the present invention is highly suitable for the prevention or treatment of metabolic diseases, particularly obesity, diabetes and diabetic complications, and exerts excellent in vivo efficacy. The Rg3 group ginsenoside produced by the present invention exerts excellent in vivo efficacy against various diabetic complications and is very effective in relieving the symptoms of diabetic patients in the early, middle, and late stages of diabetes. |
| isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-20180024914-A http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-101950341-B1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-101718355-B1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-20210029345-A |
| priorityDate | 2012-01-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 309.